Muneaki Shimada
Papers
1
Total Citations
15
H-Index
1
About
Muneaki Shimada is a leading figure in gynecologic oncology, whose research focuses on optimizing surgical and therapeutic strategies for ovarian cancer. His major contributions center on evidence-based comparisons of surgical approaches, most notably through a landmark 2024 systematic review and meta-analysis that rigorously evaluated the efficacy and safety of minimally invasive surgery versus open laparotomy for epithelial ovarian cancer. This work, which has already garnered 15 citations, provides critical guidance for clinicians navigating the balance between surgical precision and patient recovery. Beyond this, Shimada’s broader research portfolio addresses prognostic factors, chemotherapy outcomes, and quality-of-life considerations in ovarian cancer management. His meta-analytical approach has helped clarify long-standing debates in surgical oncology, offering data-driven insights that directly influence treatment protocols. Shimada’s work is characterized by its methodological rigor and clinical relevance, making him a trusted voice in the field. For students and researchers, his studies exemplify how systematic synthesis of existing evidence can drive meaningful improvements in patient care, particularly in the nuanced realm of gynecologic cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1